Merck & Co. stock slightly lower pre-market before October 26 event
Published on 10/19/2026 at 08:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSUpcoming investor agenda
- Merck & Co. has scheduled an investor event connected with ESMO 2026 for October 26, 2026.
- The company develops human-health pharmaceuticals and also provides veterinary pharmaceuticals, vaccines and health-management services.
- Merck & Co. stock trades pre-market at EUR 130.00 at 8:29 a.m. CEST at Lang & Schwarz on October 19, 2026, 0.41 percent below the Xetra close of October 16, 2026.
Merck & Co. lists an Investor Event at ESMO 2026 for October 26, 2026, on its investor-relations website. The stock trades pre-market at EUR 130.00 at 8:29 a.m. CEST at Lang & Schwarz on October 19, 2026, 0.41 percent below the Xetra close of October 16, 2026 (EUR 130.54).
Upcoming investor agenda
The company’s investor-relations page identifies the October 26 event as an Investor Event at ESMO 2026 and provides conference dial-in details. The event is listed among Merck’s latest investor events and financial information on the company’s website, which also identifies the issuer as NYSE-listed Merck & Co., Inc. Merck & Co. investor relations.
Ahead of the Xetra open
The indication is EUR minus 0.54 versus Friday’s reference level, placing the pre-market price below the last Xetra session. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Merck & Co. stock.
The group and its market
Merck & Co. develops human-health pharmaceuticals and also provides veterinary pharmaceuticals, vaccines and health-management solutions and services, according to a company profile carried by Yahoo Finance. The October 26 ESMO investor event is the next dated item listed on Merck’s investor-relations page. Market context: Market report S&P 500.
